The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Oral Presentation(C) Pharmaceutical Biology

[27-12-pm]Virology

Thu. Mar 27, 2025 1:15 PM - 2:51 PM JST
Thu. Mar 27, 2025 4:15 AM - 5:51 AM UTC
Room 12 (Fukuoka International Congress Center: 414 [4F])
Chair: Kahori Shimizu, Naoki Kishimoto
1:15 PM - 1:27 PM JST(4:15 AM - 4:27 AM UTC)

[27-12-pm01S]Elucidation of the effects of enterovirus A71 infection on enteric nervous system using human ES/iPS cell-derived intestinal models

○Hiroki Futatsusako1, Sayaka Deguchi1, Rina Hashimoto1, Kazuo Takayama1 (1. Center for iPS Cell Research and Application (CiRA), Kyoto Univ.)
1:27 PM - 1:39 PM JST(4:27 AM - 4:39 AM UTC)

[27-12-pm02S]Functional analysis of mpox virus (MPXV) OPG175 gene

○Yoshitaka Nakata1, Yukio Watanabe1, Keiya Uriu2, Rina Hashimoto1, Takuya Yamamoto1, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato2, Akatsuki Saito3, Kazuo Takayama1 (1. CiRA, Kyoto Univ., 2. Inst. Med. Sci., Univ. of Tokyo, 3. Fac. Agric, Univ. of Miyazaki)
1:39 PM - 1:51 PM JST(4:39 AM - 4:51 AM UTC)

[27-12-pm03]Analysis of the antiviral effect on the marine-organism originated lectins against the highly pathogenic viruses

○Shuzo Urata1, Meion Lee1,2, Tomoko Tsuruta1, Reo Igarashi1, Kohsuke Takeda2, Hideaki Unno3 (1. CCPID, Nagasaki University, 2. Grad. Sch. Biomed. Sci., Nagasaki University, 3. Grad. Sch. Engineering, Nagasaki University)
1:51 PM - 2:03 PM JST(4:51 AM - 5:03 AM UTC)

[27-12-pm04]Studies on the inhibition of viral proteases by isoflavones with anti-coronavirus effects

○Honoka Takahashi1, Haruna Matsubayashi1, Shogo Kameda1, Masayo Ogawa1, Masaya Takemoto1, Tohru Daikoku1 (1. Faculty Pharm. Sci., Hokuruku Univ.)
2:03 PM - 2:15 PM JST(5:03 AM - 5:15 AM UTC)

[27-12-pm05S]Development of a virus-like particle vaccine against enterovirus D68

○Kotaro Taniguchi1,2, Kota Senpuku1,2, Tatsuya Karaki2,3, Yuta Kunishima2,3, Toshiro Hirai1,2,4,5, Shuko Nakamura3, Yasuo Yoshioka1,2,3,4,5,6,7 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. RIMD, Osaka Univ., 3. BIKEN, 4. OTRI, Osaka Univ., 5. CAMaD, Osaka Univ., 6. MEI, Osaka Univ., 7. CiDER, Osaka Univ.)
2:15 PM - 2:27 PM JST(5:15 AM - 5:27 AM UTC)

[27-12-pm06S]Identification of host factors and their impact on Ebola virus particle formation

○Hina Miyazaki1, Shungo Adachi2, Kosuke Takada1, Shintaro Shichinohe1, Itsuki Anzai1,3, Tokiko Watanabe1,3,4 (1. RIMD, Osaka Univ., 2. NCC, 3. CiDER, 4. CAMaD)
2:27 PM - 2:39 PM JST(5:27 AM - 5:39 AM UTC)

[27-12-pm07]Mechanistic characterization of SARS-CoV-2 manipulation of autophagy for its replication

○Itsuki Anzai1,2, Shungo Adachi3, Tokiko Watanabe1,2,4 (1. RIMD, Osaka Univ., 2. CiDER, Osaka Univ., 3. NCCRI, 4. CAMaD, Osaka Univ.)
2:39 PM - 2:51 PM JST(5:39 AM - 5:51 AM UTC)

[27-12-pm08]Functional analysis of SARS-CoV-2 variant spike proteins

○Yuichiro Yamamoto1, Miyu Furukawa 1, Koru Sato1, Koji Noguchi1 (1. Facult. Pharm. Sci., Tokyo Univ. Sci.)
Back to Category List